血小板体积指数对可切除食管鳞状细胞癌患者预后的评估价值OACSTPCD
Prognostic value of platelet volume indices in patients with resectable esophageal squa-mous cell carcinoma
目的 探讨术前血小板体积指数(PVI)对可切除食管鳞状细胞癌(ESCC)患者预后的评估价值.方法 回顾性分析 2013-03 至 2023-06 进行手术治疗的 210 例ESCC患者的临床资料,根据患者术前各项PVI指数的受试者工作特征曲线(ROC)获得截断值,Kaplan-Meier方法和COX模型分析了PVI对ESCC患者预后的影响.结果 随访 5 年,125 例(59.52%)患者死亡,中位OS为 15.0 个月(范围 3~60 个月).与存活组比较,死亡组血小板计数(PLT)[250.50(205.0,300.50)vs.212.50(179.50,278.50),Z=-2.801,P=0.005]、血小板分布宽度(PDW)[12.90(11.80,15.80)FL vs.11.30(10.40,14.95)FL,Z=-2.665,P=0.008]均有所升高(P<0.05),PDW/PLT[12.90(11.80,15.80)vs.11.30(10.20,15.05),Z=-6.719,P<0.001]显著升高,平均血小板体积(MPV)/PLT[0.04(0.03,0.04)vs.0.05(0.04,0.06),Z=-10.847,P<0.001]显著降低.受试者工作特征曲线显示PLT、PDW、MPV/PLT、PDW/PLT都可以用于预测可切除ESCC患者的死亡风险(P<0.05),但PLT、PDW的临床价值不高[曲线下面积(AUC)<0.7];当MPV/PLT≥0.043 或PDW/PLT≥60.230 时,AUC值分别为 0.771 和 0.802;当两者联合时,预测死亡风险的AUC值升高至 0.929.相对MPV/PLT>0.043、PDW/PLT≤60.230 的患者,MPV/PLT≤0.043(Log-Rank=34.502,P<0.001)、PDW/PLT>60.230(Log-Rank=172.056,P<0.001)的ESCC患者总生存期(OS)更短.经COX多因素模型分析,发现PDW/PLT>60.230、MPV/PLT>0.043 与ESCC患者术后死亡独立相关(P<0.05).结论 PVI是可切除ESCC患者术后的潜在预后指标,尤其是MPV/PLT和PDW/PLT联合检测的临床预后价值更理想.
Objective To evaluate the prognostic value of platelet volume indices(PVI)in patients with resectable esophage-al squamous cell carcinoma(ESCC).Methods Clinical data of 210 patients with ESCC who underwent surgery from March 2013 to June 2023 were retrospectively analyzed,and the cut-off values of PVI were obtained from the receiver operating characteristic curve(ROC),and the Kaplan-Meier method and COX model were used to analyze the effect of PVI index on the prognosis of ESCC patients.Results During a 5-year follow-up,125 patients(59.52%)died,with a median OS of 15.0 months(range of 3-60 months).Com-pared with the survival group,platelet count(PLT)in the death group[250.50(205.0,300.50)vs.212.50(179.50,278.50),Z=-2.801,P=0.005],platelet distribution width(PDW)in the death group[12.90(11.80,15.80)FL vs.11.30(10.40,14.95)FL,Z=-2.665,P=0.008]increased(P<0.05),PDW/PLT[12.90(11.80,15.80)vs.11.30(10.20,15.05),Z=-6.719,P<0.001]significantly increased,and the mean platelet volume(MPV)/PLT significantly decreased[0.04(0.03,0.04)vs.0.05(0.04,0.06),Z=-10.847,P<0.001].The receiver operating characteristic curve showed that PLT,PDW,MPV/PLT and PDW/PLT could all be used to predict the mortality risk of patients with resectable ESCC,P<0.05,but the clinical value of PLT and PDW was not high[area under the curve(AUC)<0.7];when MPV/PLT≥0.043 or PDW/PLT≥60.230,the AUC values were 0.771 and 0.802,respectively,and when the two were combined,the AUC values for predicting mortality risk increased to 0.929.Compared with patients with MPV/PLT>0.043 and PDW/PLT≤60.230,the overall survival(OS)of ESCC patients with MPV/PLT≤0.043(Log-Rank=34.502,P<0.001)and PDW/PLT>60.230(Log-Rank=172.056,P<0.001)was shorter.The COX multivariate model analysis showed that PDW/PLT>60.230 and MPV/PLT>0.043 were independently associated with postoperative mortality in ESCC patients(P<0.05).Conclusions PVI is a potential prognostic indicator for resectable ESCC patients after surgery,especially the clinical prognostic value of combined detection of MPV/PLT and PDW/PLT is more ideal.
岳翔;黄浩;王雯;田莽
721000 宝鸡,联勤保障部队第987医院心胸泌尿外科430064 武汉,中部战区总医院心胸外科716000,延安大学医学院
临床医学
可切除食管鳞状细胞癌预后血小板体积指数MPV/PLTPDW/PLT
resectable esophageal squamous cell carcinomaprognosisplatelet volume indicesMPV/PLTPDW/PLT
《武警医学》 2024 (009)
763-769 / 7
军队某课题资助
评论